BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.157
-0.011 (-6.61%)
Mar 6, 2026, 10:02 AM EST - Market open
BioAtla Market Cap
BioAtla has a market cap or net worth of $11.64 million as of March 6, 2026. Its market cap has decreased by -57.16% in one year.
Market Cap
11.64M
Enterprise Value
10.33M
1-Year Change
-57.16%
Ranking
Category
Stock Price
$0.16
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $11.64M, a decrease of -97.98%. That is a compound annual growth rate of -52.67%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Traws Pharma | 13.42M |
| Kairos Pharma | 13.11M |
| NewcelX | 12.99M |
| BioLineRx | 12.76M |
| BioCardia | 12.63M |
| Can-Fite BioPharma | 12.63M |
| Phio Pharmaceuticals | 12.38M |
| Cellectar Biosciences | 12.30M |